Capital Research Global Investors 13D and 13G filings for CONMED Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 12:53 pm Sale |
2024-11-07 | 13G | CONMED Corporation CNMD |
Capital Research Global Investors | 1,544,542 5.000% |
-1,212,566 (-43.98%) |
Filing |
| 2024-02-09 5:49 pm Purchase |
2024-02-07 | 13G | CONMED Corporation CNMD |
Capital Research Global Investors | 2,757,108 9.000% |
564,714 (+25.76%) |
Filing |
| 2023-02-13 3:32 pm Purchase |
2023-02-14 | 13G | CONMED Corporation CNMD |
Capital Research Global Investors | 2,192,394 7.200% |
1,474,094 (+205.22%) |
Filing |
| 2021-02-16 3:28 pm Sale |
2021-02-16 | 13G | CONMED Corporation CNMD |
Capital Research Global Investors | 718,300 2.500% |
-1,438,351 (-66.69%) |
Filing |